Full Text:
<2773>
CLC number: Q354
On-line Access:
Received: 2005-11-22
Revision Accepted: 2005-12-26
Crosschecked: 0000-00-00
Cited: 0
Clicked: 5236
Human cancer genetics
| |||||||||||||
Li Marilyn, Albertson Donna. Human cancer genetics[J]. Journal of Zhejiang University Science B, 2006, 7(2): 164-164.
@article{title="Human cancer genetics",
author="Li Marilyn, Albertson Donna",
journal="Journal of Zhejiang University Science B",
volume="7",
number="2",
pages="164-164",
year="2006",
publisher="Zhejiang University Press & Springer",
doi="10.1631/jzus.2006.B0164"
}
%0 Journal Article
%T Human cancer genetics
%A Li Marilyn
%A Albertson Donna
%J Journal of Zhejiang University SCIENCE B
%V 7
%N 2
%P 164-164
%@ 1673-1581
%D 2006
%I Zhejiang University Press & Springer
%DOI 10.1631/jzus.2006.B0164
TY - JOUR
T1 - Human cancer genetics
A1 - Li Marilyn
A1 - Albertson Donna
J0 - Journal of Zhejiang University Science B
VL - 7
IS - 2
SP - 164
EP - 164
%@ 1673-1581
Y1 - 2006
PB - Zhejiang University Press & Springer
ER -
DOI - 10.1631/jzus.2006.B0164
Abstract: The short report will be focused on the genetic basis and possible mechanisms of tumorigenesis, common types of cancer, the importance of genetic diagnosis of cancer, and the methodology of cancer genetic diagnosis. They will also review presymptomatic testing of hereditary cancers, and the application of expression profiling to identify patients likely to benefit from particular therapeutic approaches.
[1] Jiang, G.C., Young, F., Li, M., Weissbecker, K., Price, S., Kim, K.C., Rice, J., La Russa, V.F., Safah, H., Ehrlich, M., 2003. Imtinib (STI571) provides only limited selectivity for CML cells and treatment might be complicated by silent SCR/ABL genes. Cancer Biology & Therapy, 2(1):166/1-166/7.
[2] Kops, G.J., Weaver, B.A., Cleveland, D.W., 2005. On the road to cancer: aneuploidy and the mitotic checkpoint. Nat. Rev. Cancer, 5(10):773-785.
[3] Pinkel, D., Albertson, D.G., 2005. Array comparative genomic hybridization and its applications in cancer. Nat. Genet., 37(Suppl 6):S11-S17.
Open peer comments: Debate/Discuss/Question/Opinion
<1>